BIPP Grant (Biotechnology Industry Partnership Programme)
Funds Indian biotechnology partnerships with industry to pursue frontier life-science breakthroughs at early stage.
The Biotechnology Industry Partnership Programme (BIPP) Grant is BIRAC's largest biotech industry-partnership grant, providing up to INR 25 Crore (₹250,000,000) per project for path-breaking research in frontier futuristic technology areas on a cost-sharing public-private partnership basis. BIRAC — the Biotechnology Industry Research Assistance Council, a Government of India enterprise under the Department of Biotechnology — established BIPP to fund multi-year, high-impact R&D programmes where Indian biotech industry partners co-invest alongside government support. Eligible technology areas include next-generation diagnostics, novel therapeutics, advanced biomanufacturing, biotech platforms, agricultural biotech, synthetic biology, and other high-commercial-impact emerging fields. BIPP scheme guidelines were most recently updated 16 April 2025.
Awards range from approximately INR 2 Crore to INR 25 Crore (₹20 million to ₹250 million), with an estimated median of INR 10 Crore. The estimated annual pool is approximately INR 200 Crore (₹2 billion), reflecting BIPP's large per-grant tickets within BIRAC's annual funding envelope. Project duration is typically two to four years, with funding disbursed in milestone-based installments. The cost-sharing PPP structure requires the Indian industry partner to provide cash and in-kind co-funding throughout the project lifecycle. Significant equipment cost support is available as part of larger BIPP awards. Special provisions exist for start-ups that have not previously received BIRAC funding, making them eligible for up to an additional INR 50 Lakhs in support.
Eligible applicants are Indian-registered biotech companies as primary recipients, with universities, research institutions, and non-profits eligible as project partners. Minimum TRL at entry is 4, targeting candidates through TRL 7. BIPP is targeted at organizations with the capacity to execute multi-year industrial R&D and to provide the required co-funding. A strong application demonstrates the frontier nature of the proposed research, the strategic significance of the technology area to Indian biotech competitiveness, the adequacy of the industry partner's co-funding commitment, and a realistic milestone plan with commercial outcomes. BIPP graduates who have completed BIRAC's earlier-stage BIG or other BIRAC programs have demonstrated track records that strengthen applications.
Indian biotech industry undertaking path-breaking research in frontier futuristic technology areas: next-generation diagnostics, novel therapeutics, biotech platforms, advanced biomanufacturing, agricultural biotech, synthetic biology, and similar high-impact emerging fields.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up